As the duration of the disease increases, the risk of developing progressive MS (PMS) grows. In this progressive phase, immunotherapies often begin to function worse and therapeutic goals need to be readjusted.

The aim of this research project is to investigate the influence of hormons on the development of physical disability and cognitive performance in MS patients.

As part of this study in collaboration with Charité - Berlin, the prognostic potential of the biomarker serum neurofilament light chain (sNfL) is to be investigated with relation to the progression of the disease and for possible treatment decisions.

The research project aims to explore determinants of participation in work life in MS patients and to identify cluster of potential influencing factors. The knowledge gained will serve to improve the chances of people with MS to participate in work life.

The aim of the EHDEN project is to harmonize the large amount of existing clinical data from different countries, institutions and data structures within the joint OMOP Common Data Model (CMD) in a common network.

The primary objectives are to investigate how well people with multiple sclerosis (MS) are cared for in Lower Saxony and to develop a patient-oriented care model that is tailored to their needs.

In order to improve the care of MS patients, a consortium including the BKK Dachverband and led by the University Medical Center Hamburg-Eppendorf (UKE) has launched the research project "Power@MS". This project aims to strengthen empowerment of MS patient.

Making medical care secure – Feasibility study on the suitability of different data sources as a basis for improving the pharmacovigilance of innovative therapies using multiple sclerosis as an example

An international network to promote research projects in the field of secondary progressive MS (SPMS) and to make specific statements on the prevalence and therapy of SPMS patients in contrast to RRMS patients and thus to be able to promote relevant developments in patient care and therapy design in the future.